+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Automated Oligonucleotide Synthesizer Market - Global Forecast to 2030- Product Image
Automated Oligonucleotide Synthesizer Market - Global Forecast to 2030- Product Image
New

Automated Oligonucleotide Synthesizer Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081163
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The field of automated oligonucleotide synthesizers stands at the intersection of biotechnology innovation and digital transformation. As the demand for custom DNA and RNA sequences accelerates across research, diagnostics, and therapeutic development, advanced synthesizer platforms are redefining throughput, accuracy and cost‐efficiency. Modern laboratories leverage fully integrated systems that combine robotics, software intelligence and scalable workflows to meet complex synthesis requirements, from high‐volume commercial scales to rapid pilot‐scale prototyping. This convergence of automation and molecular precision not only accelerates discovery pipelines but also democratizes access to bespoke oligonucleotides, empowering a broader community of scientists and clinicians to pioneer next‐generation solutions. As we explore the key shifts, regulatory forces and segmentation dynamics shaping this market, it becomes clear that strategic investments in automation are central to maintaining competitive advantage and driving sustained growth.

Transformative Shifts in the Automated Synthesizer Landscape

Over the past decade, several transformative forces have reshaped the oligonucleotide synthesizer landscape. First, microfluidic integration has enabled miniaturized, high‐throughput platforms that dramatically reduce reagent consumption and cycle times, unlocking rapid parallel synthesis. Concurrently, artificial intelligence and machine learning algorithms have been embedded within control software to optimize synthesis protocols in real time, enhancing yield and purity while minimizing human intervention. Sustainability considerations have spurred the adoption of greener chemistries and waste‐reduction modules, aligning instrument design with corporate responsibility goals. Meanwhile, modular hardware architectures allow seamless upgrades and customization, fostering broader application flexibility from academic research to industrial manufacturing. Finally, the convergence of cloud‐based data analytics and remote monitoring capabilities is empowering distributed operations, enabling on‐demand oligonucleotide production closer to end users. Together, these shifts are redefining performance benchmarks and setting new standards for reliability, scalability and environmental stewardship.

Cumulative Impact of United States Tariffs 2025

The introduction of new United States tariffs in 2025 has introduced both challenges and strategic pivot points for synthesizer manufacturers and end users. Increased duties on key components such as precision motors, specialty resins and microfluidic chips have driven up input costs, prompting OEMs to reevaluate global supply chains. Many vendors are responding by relocating assembly lines or qualifying alternative component suppliers in tariff‐exempt regions, a process that requires rigorous quality validation and may extend lead times. For buyers, higher equipment prices are accelerating interest in service‐based models and reagent‐as‐a‐service offerings, mitigating capital expenditures. At the same time, the tariff regime has catalyzed domestic investment in production capabilities, creating potential for localized innovation hubs and faster aftermarket support. As stakeholders adapt to the new cost structure, strategic sourcing, inventory management and collaborative vendor partnerships become pivotal in preserving margins and ensuring uninterrupted throughput.

Key Segmentation Insights Across Product, Application, End-User and Technology

A nuanced understanding of market segmentation reveals where growth and value creation intersect. In terms of product type, the market is investigated across Automatic Synthesizers including Fully Automatic and Semi‐Automatic, Custom Platform Synthesizers spanning Multi‐Purpose Platforms and Specialized Custom Platforms, Portable Synthesizers differentiated into On‐Site Portable and Remote Operation Portable, RNA/DNA Synthesizers comprising Microchip Synthesizers and Oligonucleotide Synthesizers, and Solid‐Phase Synthesis utilizing Microwave‐Assisted and Traditional Solid‐Phase methods. Application insights show demand driven by Agricultural Biotechnology through Crop Improvement and Genetic Engineering, Clinical and Diagnostic deployment in Disease Diagnosis and Molecular Diagnostics, Drug Development focusing on Antisense Oligonucleotides and siRNA Synthesis, Research Studies spanning Biomedical Research and Genomic Studies, and Therapeutic Applications in Cancer Treatment and Gene Therapy. End‐users range from Academic Research Institutes via Higher Education Labs and Private Research Labs, Biotech Startups operating within Innovation Incubators and Venture Labs, Hospitals and Clinics equipped with Diagnostic Labs and Research Wings, to Pharmaceutical and Biotechnology Companies utilizing Contract Research Organizations and In‐House Labs. Technology type further differentiates Automated Synthesizer Systems spanning Bench‐Top Systems and Integrated Workstations, Classical Column Synthesis covering DNA/RNA Columns and Peptide Columns, Microarray Technology with In Situ-Synthesized Arrays and Photolithographic Arrays, and Microfluidic Technology via PDMS Devices and SlipChip Devices. Distribution channels include Direct Sales through Company-Owned Sales Force and Online Platforms, E-Commerce Platforms across B2B Platforms and B2C Platforms, and Third-Party Distributors comprising Global Distributors and Regional Distributors. Scale of synthesis segments into Large-Scale Synthesis at Commercial and Industrial Scale and Small-Scale Synthesis at Pilot and Research Scale. Component analysis covers Consumables such as Columns and Plates, Reagents including Chemical Reagents and Enzymatic Reagents, and Software spanning Analysis Software and Operating Systems Software. Each of these slices reveals distinct growth drivers and procurement behaviors, highlighting where tailored marketing, service packages and R&D investments will yield the greatest impact.

Key Regional Insights and Growth Drivers

Regional dynamics vary according to infrastructure maturity, regulatory frameworks and investment climates. In the Americas, robust funding for genomics research, established industrial biotech clusters and concierge service networks continue to drive adoption of next-generation synthesizers, with the United States leading in both instrument procurement and reagent subscriptions, and Canada and Brazil showing growing interest in agricultural and clinical applications. Europe, Middle East & Africa benefit from harmonized regulatory pathways and collaborative innovation programs that lower barriers for new technology introduction, though cost containment policies in certain markets can slow procurement cycles. The Asia-Pacific region exhibits the fastest growth rates, fueled by national initiatives in China, India and Japan to bolster life sciences capacity, while emerging markets across Southeast Asia and the Middle East demonstrate rising demand for on-site portable and compact synthesis systems to support decentralized testing and point-of-care diagnostics.

Key Companies Insights and Strategic Positioning

Global competition and collaboration among technology leaders shape the competitive landscape. Agilent Technologies, Inc. continues to expand its modular synthesizer portfolio with enhanced software capabilities, while BioAutomation Corporation pioneers turnkey automation solutions aimed at small-scale research facilities. Biolytic Lab Performance Inc. focuses on high-purity reagent development, and CLC bio A/S (Qiagen) integrates bioinformatics tools directly into device control interfaces. GE Healthcare Life Sciences leverages its process development expertise to offer scalable production platforms. Gen9, Inc. (Ginkgo Bioworks) and GenScript Biotech Corporation invest in synthetic biology partnerships to co-develop proprietary synthesis chemistries. Integrated DNA Technologies, Inc. maintains market leadership through end-to-end digital ordering systems and rapid turnaround models. Kaneka Eurogentec S.A. and LGC Biosearch Technologies emphasize specialty oligonucleotides and custom modification services. Merck KGaA (MilliporeSigma) and Sartorius AG enhance their life science portfolios with cross-disciplinary solutions, while Thermo Fisher Scientific Inc. drives integration across hardware, reagents and informatics. Pacific Biosciences of California, Inc. extends its long-read sequencing strength into synthesis validation workflows. TriLink BioTechnologies, LLC and Twist Bioscience Corporation push the envelope on high-throughput chip-based synthesis and novel chemistries. Together, these players leverage geographic reach, strategic alliances and continuous innovation to capture emerging opportunities.

Actionable Recommendations for Industry Leaders

To thrive in this dynamic environment, industry leaders should adopt a multipronged approach. First, prioritizing the development of modular, upgradeable platforms will ensure long-term customer loyalty and recurring revenue through service contracts and software updates. Second, diversifying supply chains by qualifying multiple suppliers and nearshoring critical components will mitigate tariff risk and minimize production disruption. Third, investing in artificial intelligence for predictive maintenance, protocol optimization and real-time quality control will enhance reliability and unlock new value propositions. Fourth, forming strategic partnerships with life science reagent providers, bioinformatics firms and academic consortia will accelerate co-innovation and expand addressable markets. Fifth, tailoring go-to-market strategies for each segment-ranging from enterprise licensing for large pharmaceutical companies to reagent-as-a-service models for academic labs-will align offerings with end-user priorities. Finally, expanding service footprints in emerging markets through localized training, financing options and extended warranties will capture growth in high-potential regions.

Conclusion and Future Outlook

The automated oligonucleotide synthesizer market stands poised for continued evolution. With emerging technologies lowering barriers to custom synthesis and regulatory landscapes maturing, stakeholders are presented with a rare convergence of demand, innovation and strategic opportunity. By aligning investment portfolios with identified segmentation priorities, securing resilient supply networks, and leveraging data-driven automation, organizations can differentiate their value propositions and capture disproportionate share. The years ahead will favor agile, collaborative players who balance speed to market with uncompromising precision, ensuring that the next wave of oligonucleotide breakthroughs is both robust and scalable.

Market Segmentation & Coverage

This research report categorizes the Automated Oligonucleotide Synthesizer Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Automatic Synthesizers
    • Fully Automatic
    • Semi-Automatic
  • Custom Platform Synthesizers
    • Multi-Purpose Platforms
    • Specialized Custom Platforms
  • Portable Synthesizers
    • On-Site Portable
    • Remote Operation Portable
  • RNA/DNA Synthesizers
    • Microchip Synthesizers
    • Oligonucleotide Synthesizers
  • Solid-Phase Synthesis
    • Microwave-Assisted
    • Traditional Solid-Phase
  • Agricultural Biotechnology
    • Crop Improvement
    • Genetic Engineering
  • Clinical and Diagnostic
    • Disease Diagnosis
    • Molecular Diagnostics
  • Drug Development
    • Antisense Oligonucleotides
    • siRNA Synthesis
  • Research Studies
    • Biomedical Research
    • Genomic Studies
  • Therapeutic Applications
    • Cancer Treatment
    • Gene Therapy
  • Academic Research Institutes
    • Higher Education Labs
    • Private Research Labs
  • Biotech Startups
    • Innovation Incubators
    • Venture Labs
  • Hospitals and Clinics
    • Diagnostic Labs
    • Research Wings
  • Pharmaceutical and Biotechnology Companies
    • Contract Research Organizations
    • In-House Labs
  • Automated Synthesizer Systems
    • Bench-Top Systems
    • Integrated Workstations
  • Classical Column Synthesis
    • DNA/RNA Columns
    • Peptide Columns
  • Microarray Technology
    • In Situ-Synthesized Arrays
    • Photolithographic Arrays
  • Microfluidic Technology
    • PDMS Devices
    • SlipChip Devices
  • Direct Sales
    • Company-Owned Sales Force
    • Online Platforms
  • E-Commerce Platforms
    • B2B Platforms
    • B2C Platforms
  • Third-Party Distributors
    • Global Distributors
    • Regional Distributors
  • Large-Scale Synthesis
    • Commercial Scale
    • Industrial Scale
  • Small-Scale Synthesis
    • Pilot Scale
    • Research Scale
  • Consumables
    • Columns
    • Plates
  • Reagents
    • Chemical Reagents
    • Enzymatic Reagents
  • Software
    • Analysis Software
    • Operating Systems Software

This research report categorizes the Automated Oligonucleotide Synthesizer Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Automated Oligonucleotide Synthesizer Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Agilent Technologies, Inc.
  • BioAutomation Corporation
  • Biolytic Lab Performance Inc.
  • CLC bio A/S (Qiagen)
  • GE Healthcare Life Sciences
  • Gen9, Inc. (Ginkgo Bioworks)
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • Kaneka Eurogentec S.A.
  • LGC Biosearch Technologies
  • Merck KGaA (MilliporeSigma)
  • Pacific Biosciences of California, Inc.
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies, LLC
  • Twist Bioscience Corporation

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automated Oligonucleotide Synthesizer Market, by Product Type
8.1. Introduction
8.2. Automatic Synthesizers
8.2.1. Fully Automatic
8.2.2. Semi-Automatic
8.3. Custom Platform Synthesizers
8.3.1. Multi-Purpose Platforms
8.3.2. Specialized Custom Platforms
8.4. Portable Synthesizers
8.4.1. On-Site Portable
8.4.2. Remote Operation Portable
8.5. RNA/DNA Synthesizers
8.5.1. Microchip Synthesizers
8.5.2. Oligonucleotide Synthesizers
8.6. Solid-Phase Synthesis
8.6.1. Microwave-Assisted
8.6.2. Traditional Solid-Phase
9. Automated Oligonucleotide Synthesizer Market, by Application
9.1. Introduction
9.2. Agricultural Biotechnology
9.2.1. Crop Improvement
9.2.2. Genetic Engineering
9.3. Clinical and Diagnostic
9.3.1. Disease Diagnosis
9.3.2. Molecular Diagnostics
9.4. Drug Development
9.4.1. Antisense Oligonucleotides
9.4.2. siRNA Synthesis
9.5. Research Studies
9.5.1. Biomedical Research
9.5.2. Genomic Studies
9.6. Therapeutic Applications
9.6.1. Cancer Treatment
9.6.2. Gene Therapy
10. Automated Oligonucleotide Synthesizer Market, by End-User
10.1. Introduction
10.2. Academic Research Institutes
10.2.1. Higher Education Labs
10.2.2. Private Research Labs
10.3. Biotech Startups
10.3.1. Innovation Incubators
10.3.2. Venture Labs
10.4. Hospitals and Clinics
10.4.1. Diagnostic Labs
10.4.2. Research Wings
10.5. Pharmaceutical and Biotechnology Companies
10.5.1. Contract Research Organizations
10.5.2. In-House Labs
11. Automated Oligonucleotide Synthesizer Market, by Technology Type
11.1. Introduction
11.2. Automated Synthesizer Systems
11.2.1. Bench-Top Systems
11.2.2. Integrated Workstations
11.3. Classical Column Synthesis
11.3.1. DNA/RNA Columns
11.3.2. Peptide Columns
11.4. Microarray Technology
11.4.1. In Situ-Synthesized Arrays
11.4.2. Photolithographic Arrays
11.5. Microfluidic Technology
11.5.1. PDMS Devices
11.5.2. SlipChip Devices
12. Automated Oligonucleotide Synthesizer Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.2.1. Company-Owned Sales Force
12.2.2. Online Platforms
12.3. E-Commerce Platforms
12.3.1. B2B Platforms
12.3.2. B2C Platforms
12.4. Third-Party Distributors
12.4.1. Global Distributors
12.4.2. Regional Distributors
13. Automated Oligonucleotide Synthesizer Market, by Oligonucleotide Synthesis Scale
13.1. Introduction
13.2. Large-Scale Synthesis
13.2.1. Commercial Scale
13.2.2. Industrial Scale
13.3. Small-Scale Synthesis
13.3.1. Pilot Scale
13.3.2. Research Scale
14. Automated Oligonucleotide Synthesizer Market, by Component
14.1. Introduction
14.2. Consumables
14.2.1. Columns
14.2.2. Plates
14.3. Reagents
14.3.1. Chemical Reagents
14.3.2. Enzymatic Reagents
14.4. Software
14.4.1. Analysis Software
14.4.2. Operating Systems Software
15. Americas Automated Oligonucleotide Synthesizer Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Automated Oligonucleotide Synthesizer Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Automated Oligonucleotide Synthesizer Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Agilent Technologies, Inc.
18.3.2. BioAutomation Corporation
18.3.3. Biolytic Lab Performance Inc.
18.3.4. CLC bio A/S (Qiagen)
18.3.5. GE Healthcare Life Sciences
18.3.6. Gen9, Inc. (Ginkgo Bioworks)
18.3.7. GenScript Biotech Corporation
18.3.8. Integrated DNA Technologies, Inc.
18.3.9. Kaneka Eurogentec S.A.
18.3.10. LGC Biosearch Technologies
18.3.11. Merck KGaA (MilliporeSigma)
18.3.12. Pacific Biosciences of California, Inc.
18.3.13. Sartorius AG
18.3.14. Thermo Fisher Scientific Inc.
18.3.15. TriLink BioTechnologies, LLC
18.3.16. Twist Bioscience Corporation
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET MULTI-CURRENCY
FIGURE 2. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET MULTI-LANGUAGE
FIGURE 3. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS SCALE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 20. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATIC SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY FULLY AUTOMATIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SEMI-AUTOMATIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATIC SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CUSTOM PLATFORM SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MULTI-PURPOSE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SPECIALIZED CUSTOM PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CUSTOM PLATFORM SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PORTABLE SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ON-SITE PORTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REMOTE OPERATION PORTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PORTABLE SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA/DNA SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROCHIP SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA/DNA SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROWAVE-ASSISTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TRADITIONAL SOLID-PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLINICAL AND DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLINICAL AND DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SIRNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY GENOMIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH STUDIES, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HIGHER EDUCATION LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRIVATE RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BIOTECH STARTUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INNOVATION INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY VENTURE LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BIOTECH STARTUPS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH WINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY IN-HOUSE LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATED SYNTHESIZER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BENCH-TOP SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INTEGRATED WORKSTATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATED SYNTHESIZER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLASSICAL COLUMN SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DNA/RNA COLUMNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PEPTIDE COLUMNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLASSICAL COLUMN SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY IN SITU-SYNTHESIZED ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHOTOLITHOGRAPHIC ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROFLUIDIC TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PDMS DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SLIPCHIP DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROFLUIDIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COMPANY-OWNED SALES FORCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY B2B PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY B2C PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY E-COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY GLOBAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY LARGE-SCALE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY INDUSTRIAL SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY LARGE-SCALE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SMALL-SCALE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PILOT SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SMALL-SCALE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COLUMNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 109. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 110. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CHEMICAL REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 111. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ENZYMATIC REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 112. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 113. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 114. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 115. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY OPERATING SYSTEMS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 116. GLOBAL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATIC SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CUSTOM PLATFORM SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PORTABLE SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA/DNA SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLINICAL AND DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH STUDIES, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BIOTECH STARTUPS, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 133. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 134. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 135. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATED SYNTHESIZER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLASSICAL COLUMN SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 137. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROFLUIDIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 141. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY E-COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 142. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 143. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 144. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY LARGE-SCALE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 145. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SMALL-SCALE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 146. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 147. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 148. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 149. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 150. AMERICAS AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATIC SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CUSTOM PLATFORM SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PORTABLE SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA/DNA SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLINICAL AND DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH STUDIES, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BIOTECH STARTUPS, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATED SYNTHESIZER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLASSICAL COLUMN SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROFLUIDIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY E-COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY LARGE-SCALE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SMALL-SCALE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATIC SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CUSTOM PLATFORM SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PORTABLE SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA/DNA SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLINICAL AND DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH STUDIES, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 198. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BIOTECH STARTUPS, 2018-2030 (USD MILLION)
TABLE 199. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 200. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 201. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 202. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATED SYNTHESIZER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 203. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLASSICAL COLUMN SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 204. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROFLUIDIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 208. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY E-COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 209. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 210. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 211. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY LARGE-SCALE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 212. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SMALL-SCALE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 213. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 214. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 215. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 216. BRAZIL AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 217. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATIC SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 219. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CUSTOM PLATFORM SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 220. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PORTABLE SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 221. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA/DNA SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 222. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 223. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLINICAL AND DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 226. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 227. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH STUDIES, 2018-2030 (USD MILLION)
TABLE 228. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 229. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 231. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BIOTECH STARTUPS, 2018-2030 (USD MILLION)
TABLE 232. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 233. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 234. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 235. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATED SYNTHESIZER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLASSICAL COLUMN SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 237. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROFLUIDIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 241. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY E-COMMERCE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 242. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 243. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 244. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY LARGE-SCALE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 245. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SMALL-SCALE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 246. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 247. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 248. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 249. CANADA AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 250. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATIC SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 252. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CUSTOM PLATFORM SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 253. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PORTABLE SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 254. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RNA/DNA SYNTHESIZERS, 2018-2030 (USD MILLION)
TABLE 255. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 256. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLINICAL AND DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 259. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 260. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY RESEARCH STUDIES, 2018-2030 (USD MILLION)
TABLE 261. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 262. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 264. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY BIOTECH STARTUPS, 2018-2030 (USD MILLION)
TABLE 265. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 266. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 267. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 268. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY AUTOMATED SYNTHESIZER SYSTEMS, 2018-2030 (USD MILLION)
TABLE 269. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY CLASSICAL COLUMN SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 270. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY MICROFLUIDIC TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. MEXICO AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD

Companies Mentioned

  • Agilent Technologies, Inc.
  • BioAutomation Corporation
  • Biolytic Lab Performance Inc.
  • CLC bio A/S (Qiagen)
  • GE Healthcare Life Sciences
  • Gen9, Inc. (Ginkgo Bioworks)
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • Kaneka Eurogentec S.A.
  • LGC Biosearch Technologies
  • Merck KGaA (MilliporeSigma)
  • Pacific Biosciences of California, Inc.
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies, LLC
  • Twist Bioscience Corporation

Methodology

Loading
LOADING...

Related Reports

Automatic Nucleic Acid Synthesizer Market - Global Forecast to 2030 - Product Image

Automatic Nucleic Acid Synthesizer Market - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Automatic Nucleic Acid Synthesizer Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Automatic Nucleic Acid Synthesizer Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 93 Pages
  • Global
From
Oligonucleotide Synthesizer Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Oligonucleotide Synthesizer Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 91 Pages
  • Global
From
DNA Synthesizer - Global Strategic Business Report - Product Image

DNA Synthesizer - Global Strategic Business Report

  • Report
  • 221 Pages
  • Global
From
U.S. Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report by Product & Service (Oligonucleotides, Equipment/Synthesizer), Application (PCR Primers, Sequencing), End-use, and Segment Forecasts, 2024-2030 - Product Image

U.S. Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report by Product & Service (Oligonucleotides, Equipment/Synthesizer), Application (PCR Primers, Sequencing), End-use, and Segment Forecasts, 2024-2030

  • Report
  • 90 Pages
  • United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.